Page 23 - தொடர்பாக முன்னோக்கி பார்க்கிறது அறிக்கைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
ADVANZ PHARMA Corp Limited Announces Fourth Quarter and 2020 Results
newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.
Lennar Announces $4 Billion Single Family Rental Platform with Centerbridge Partners as Lead Investor
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Lennar Announces $4 Billion Single Family Rental Platform with Centerbridge Partners as Lead Investor
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
FORT LAUDERDALE, Fla., March 16, 2021 /PRNewswire/ Graystone Company, Inc. (OTC: GYST) announced today the completion of the formulation of one of its signature products, Fucoidan Longevity Booster, the flagship product for its Immune Support, Anti-Inflammatory & Anti-Aging Product Line.
The Fucoidan Longevity Booster represents the initial product in the expected line of products that will address immune support, anti- inflammatory and anti-aging. Independent studies(1) on fucoidan suggest that it can prevent the growth of cancer cells and has antiviral, neuroprotective, and immune-modulating effects. Additionally, published papers(2) have reported that fucoidan may exert a range of beneficial effects on the human immune system, including the reduction of allergic responses and the activation of dendritic cells, natural killer cells and T cells. It has also been shown that fucoidan has the potential to boost important anti-viral, ant
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Lennar Reports First Quarter EPS of $3.20
March 16, 2021 GMT
MIAMI, March 16, 2021 /PRNewswire/
Net earnings of $1.0 billion, or $3.20 per diluted share, compared to net earnings of $398.5 million, or $1.27 per diluted share – both up over 150%
Excluding the pretax gain of $469.7 million ($358.7 million after tax) related to the mark to market of a strategic investment that went public, EPS would have been $2.04 per diluted share
Deliveries of 12,314 homes – up 19%
New orders of 15,570 homes – up 26%; new orders dollar value of $6.5 billion – up 31%
Backlog of 22,077 homes – up 25%; backlog dollar value of $9.5 billion – up 32%